ClinVar Miner

Submissions for variant NM_182476.3(COQ6):c.395A>G (p.Asp132Gly)

gnomAD frequency: 0.00144  dbSNP: rs45496292
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000676228 SCV000251271 uncertain significance not provided 2018-11-16 criteria provided, single submitter clinical testing A variant of unknown significance has been identified in the COQ6 gene. The D132G (c.395 A>G) variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The D132G missense change is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals. In silico analysis is inconsistent in its predictions as to whether or not the D132G variant is damaging to the protein structure/function. Several in silico splice prediction models predict that the c.395 A>G nucleotide substitution, responsible for D132G, creates a cryptic donor site which may supplant the natural donor site and lead to abnormal gene splicing. However, in the absence of RNA/functional studies, the actual effect of this sequence change in this individual is unknown. Therefore, based on the currently available information, it is unclear whether the D132G (c.395 A>G) variant is a pathogenic mutation or a rare benign variant.0
Mayo Clinic Laboratories, Mayo Clinic RCV000676228 SCV000801982 uncertain significance not provided 2023-06-16 criteria provided, single submitter clinical testing BS1, PP3
Invitae RCV000676228 SCV001023795 likely benign not provided 2024-01-26 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003937730 SCV004750848 likely benign COQ6-related condition 2020-09-21 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.